# Clinical Evaluation of NeoPlex4 Assay and NeoPlex System

> **NCT01488721** · — · COMPLETED · sponsor: **Luminex Corporation** · enrollment: 7462 (actual)

## Conditions studied

- Adrenal Hyperplasia, Congenital
- Congenital Hypothyroidism
- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01488721
- **Lead sponsor:** Luminex Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-02
- **Final completion:** 2012-04
- **Target enrollment:** 7462 (ACTUAL)
- **Last updated:** 2012-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01488721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01488721, "Clinical Evaluation of NeoPlex4 Assay and NeoPlex System". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01488721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*